Sun Pharmaceutical has a total of 8,306 patents globally, out of which 3,131 have been granted. Of these, around 37.69% patents are active. India is where Sun Pharmaceutical has filed the maximum number of patents, followed by the United States and Europe (EPO). Parallelly, India seems to be the main focused R&D centre and also is the origin country of Sun Pharmaceutical.
Founded in 1983, Sun Pharmaceutical is a global pharmaceutical company known for developing and manufacturing affordable generic and specialty medicines across key therapeutic areas such as cardiology, oncology, and dermatology.
The company is expanding its global presence, recently announcing a planned $11.75 billion acquisition of Organon to strengthen its specialty and women’s health portfolio.
How many patents does Sun Pharmaceutical have?
Sun Pharmaceutical has a total of 8306 patents globally. These patents belong to 2219 unique patent families. Out of 8306 patents, 2232 patents are active.
How Many Patents did Sun Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Sun Pharmaceutical Applications Filed | Sun Pharmaceutical Patents Granted |
| 2026 | 4 | 27 |
| 2025 | 58 | 111 |
| 2024 | 126 | 165 |
| 2023 | 133 | 131 |
| 2022 | 147 | 139 |
| 2021 | 178 | 125 |
| 2020 | 209 | 98 |
| 2019 | 177 | 114 |
| 2018 | 172 | 167 |
| 2017 | 327 | 156 |
How many Sun Pharmaceutical patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sun Pharmaceutical File in Different Countries?
Top Countries in which Sun Pharmaceutical Filed Patents
| Country | Patent |
| India | 1296 |
| United States Of America | 1292 |
| Europe | 753 |
| Japan | 341 |
| Australia | 322 |
| Canada | 286 |
| China | 268 |
| Germany | 236 |
| Hong Kong (S.A.R.) | 219 |
| Austria | 198 |
| South Africa | 153 |
| Mexico | 133 |
| Brazil | 130 |
| Spain | 129 |
| South Korea | 122 |
| Israel | 110 |
| Italy | 106 |
| Poland | 72 |
| New Zealand | 71 |
| Denmark | 61 |
| Singapore | 61 |
| Russia | 57 |
| Portugal | 54 |
| Eurasia | 51 |
| Hungary | 46 |
| Norway | 44 |
| Malaysia | 43 |
| Philippines | 36 |
| Slovenia | 35 |
| Africa | 58 |
| Taiwan | 31 |
| Croatia | 30 |
| Malta | 24 |
| Turkey | 21 |
| Cyprus | 18 |
| Indonesia | 18 |
| Viet Nam | 17 |
| Slovakia | 17 |
| Estonia | 16 |
| Argentina | 16 |
| United Kingdom | 15 |
| Serbia | 13 |
| Finland | 13 |
| Thailand | 12 |
| Chile | 11 |
| Colombia | 10 |
| Ukraine | 10 |
| Lithuania | 10 |
| Jordan | 8 |
| Morocco | 7 |
| Algeria | 7 |
| Albania | 7 |
| Peru | 6 |
| Tunisia | 6 |
| Saudi Arabia | 5 |
| Montenegro | 4 |
| San Marino | 4 |
| Ecuador | 4 |
| Costa Rica | 4 |
| Cuba | 4 |
| Romania | 4 |
| Macao | 4 |
| Georgia | 3 |
| Mongolia | 3 |
| Bangladesh | 2 |
| Uzbekistan | 2 |
| Kenya | 2 |
| Egypt | 2 |
| Czech Republic | 2 |
| United Arab Emirates | 2 |
| Nicaragua | 2 |
| Republic Of Moldova | 1 |
| Belize | 1 |
| Dominican Republic | 1 |
| Switzerland | 1 |
| North Macedonia | 1 |
Where are Research Centres of Sun Pharmaceutical Patents Located?
10 Best Sun Pharmaceutical Patents
US20090137457A1 is the most popular patent in the Sun Pharmaceutical portfolio. It has received 446 citations so far from companies like Companies, Abbott Laboratories, Cadila Pharmaceuticals Limited and Abbvie Inc.
Below is the list of 10 most cited patents of Sun Pharmaceutical:
| Publication Number | Citation Count |
| US20090137457A1 | 446 |
| US20090131363A1 | 374 |
| US7528131B2 | 344 |
| US7514068B2 | 331 |
| US7973049B2 | 172 |
| WO2013131018A1 | 149 |
| US20120083487A1 | 147 |
| US8188110B2 | 143 |
| WO2010062692A1 | 143 |
| WO2007102241A1 | 143 |
What Percentage of Sun Pharmaceutical US Patent Applications Were Granted?
Sun Pharmaceutical (Excluding its subsidiaries) has filed 291 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 166 have been granted leading to a grant rate of 64.84%.
Below are the key stats of Sun Pharmaceutical patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Sun Pharmaceutical?
| Law Firm | Total Applications | Success Rate |
| Sun Pharma (In House Dpt.) | 112 | 60.71% |
| Blank Rome Llp | 42 | 100.00% |
| Medler Ferro Woodhouse & Mills Pllc | 33 | 59.26% |
| Sughrue Mion Pllc | 23 | 52.38% |
| Goodwin Procter Llp | 21 | 52.63% |
| Mcdonnell Boehnen Hulbert & Berghoff Llp | 11 | 100.00% |
| Merchant & Gould P C | 11 | 54.55% |
| Foley & Lardner Llp | 10 | 100.00% |
| Whda Llp | 10 | 50.00% |
| Paratus Law Group Pllc | 3 | 100.00% |
What are Sun Pharmaceutical key innovation segments?
What Technologies are Covered by Sun Pharmaceutical?
The chart below distributes patents filed by Sun Pharmaceutical in different countries on the basis of the technology protected in patents. It also represents the markets where Sun Pharmaceutical thinks it’s important to protect particular technological inventions.
R&D Focus: How has Sun Pharmaceutical search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Sun Pharmaceutical?
